| abstract |
Disclosed is a method for treating and / or preventing bacterial infection in a subject and / or a disease associated with or caused by a bacterial infection. A method of treating bacterial infection in a subject comprising the following steps: a subject diagnosed with the bacterial infection, or one of the bacterial infections Topically administering a composition comprising sNAG nanofibers to a subject exhibiting more than one symptom, wherein more than 50% of the sNAG nanofibers are about The sNAG nanofibers have a length between 1 and 15 μm and do not affect bacterial growth or survival of Staphylococcus aureus bacterial cultures in vitro, and the sNAG nanofibers are muscle A process that is non-reactive when tested in an in-place test. [Selection] Figure 1 |